Niloofar Anooshiravani
Dermatology · Dearborn, MINPI 1053729129
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.2% of the total across 67 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 23 manufacturers reported payments, led by Regeneron Healthcare Solutions, Inc. at 26.8% of the total. 2025 is the largest year on record at $1,319, 2.0 times the $659 reported in 2023. That places this record below the midpoint for dermatology clinicians in MI, where the typical reported total is $2,933.
Across 67 payments — averaging $40.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Regeneron Healthcare Solutions, Inc.$727
- Sanofi$327
- Johnson & Johnson$274
- Boehringer Ingelheim$162
- AbbVie$161
- Krystal Biotech Inc$120
- plus $939 from 17 others
What the payments were for
- Food & beverage$2,63497%
- Education$753%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 14 | $727 |
| Sanofi | 7 | $327 |
| Johnson & Johnson | 7 | $274 |
| Boehringer Ingelheim | 3 | $162 |
| AbbVie | 7 | $161 |
| Krystal Biotech Inc | 1 | $120 |
| Dermavant Sciences, Inc. | 1 | $117 |
| Organon | 1 | $116 |
| UCB, Inc. | 3 | $101 |
| LEO Pharma Inc. | 1 | $89 |
| Biofrontera Inc. | 3 | $83 |
| Helsinn Therapeutics (U.S.), Inc. | 3 | $58 |
| Chiesi USA, Inc. | 3 | $58 |
| Amgen | 2 | $52 |
| Lilly USA, LLC | 2 | $45 |
| Novartis | 2 | $41 |
| Galderma Laboratories, L.p. | 1 | $38 |
| Organogenesis Inc. | 1 | $35 |
| Merck | 1 | $29 |
| Progenacare Global, LLC | 1 | $23 |
| Kyowa Kirin, Inc. | 1 | $21 |
| Fresenius Kabi USA, LLC | 1 | $17 |
| Acera Surgical, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,709 in reported general payments places this provider in the 45th percentile of 404 dermatology providers in Michigan.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Clobetasol Propionate | 35 | $1,418 |
| Ketoconazole | 44 | $765 |
| Triamcinolone Acetonide | 46 | $745 |
| Hydrocortisone | 26 | $440 |
| Doxycycline Monohydrate | 11 | $268 |
| Ammonium Lactate | 19 | $226 |
| ValacyclovirValacyclovir Hcl | 15 | $160 |
| Spironolactone | 11 | $130 |
| Minoxidil | 12 | $106 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Dearborn
- Steven DaveluyDearborn$350K
- Linda Stein GoldWest Bloomfield$3.3M
- Kristi HawleyCaledonia$2.2M
- David AltmanWarren$1.9M
- Michael SiegelWaterford$708K
- Johann GudjonssonAnn Arbor$535K
- Michael DormanWest Bloomfield$433K
- Benjamin WorkmanMidland$284K
- Diana WestgateKalamazoo$252K
- Christofer BuattiAuburn Hills$247K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.